AAAAAA

   
Results: 1-12 |
Results: 12
New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines
Authors: Spinler, SA Hilleman, DE Cheng, JWM Howard, PA Mauro, VF Lopez, LM Munger, MA Gardner, SF Nappi, JM
Citation: Sa. Spinler et al., New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines, ANN PHARMAC, 35(5), 2001, pp. 589-617
The impact of the new HEDIS guidelines: Practical considerations
Authors: Steinberg, EP Gradman, AH Lee, TH Munger, MA
Citation: Ep. Steinberg et al., The impact of the new HEDIS guidelines: Practical considerations, AM J M CARE, 6(4), 2000, pp. S190-S196
Clinical overview of antihypertensive classes - Clinically relevant differences: Myths or facts?
Authors: Gradman, AH Lee, TH Munger, MA Steinberg, EP
Citation: Ah. Gradman et al., Clinical overview of antihypertensive classes - Clinically relevant differences: Myths or facts?, AM J M CARE, 6(4), 2000, pp. S197-S210
Critical overview of antihypertensive therapies: What is preventing us from getting there?
Authors: Munger, MA Gradman, AH Lee, TH Steinberg, EP
Citation: Ma. Munger et al., Critical overview of antihypertensive therapies: What is preventing us from getting there?, AM J M CARE, 6(4), 2000, pp. S211-S221
Impact and risks of untreated hypertension on managed care
Authors: Lee, TH Gradman, AH Steinberg, EP Munger, MA
Citation: Th. Lee et al., Impact and risks of untreated hypertension on managed care, AM J M CARE, 6(4), 2000, pp. S222-S230
A chronobiologic approach to the pharmacotherapy of hypertension and angina
Authors: Munger, MA Kenney, JK
Citation: Ma. Munger et Jk. Kenney, A chronobiologic approach to the pharmacotherapy of hypertension and angina, ANN PHARMAC, 34(11), 2000, pp. 1313-1319
Growth hormone: A promising treatment for the failing heart?
Authors: Ng, TMH Kenney, JK Munger, MA
Citation: Tmh. Ng et al., Growth hormone: A promising treatment for the failing heart?, PHARMACOTHE, 20(9), 2000, pp. 1096-1106
beta-blocker therapy: A standard of care for heart failure
Authors: Munger, MA Cheang, KI
Citation: Ma. Munger et Ki. Cheang, beta-blocker therapy: A standard of care for heart failure, PHARMACOTHE, 20(11), 2000, pp. 359S-367S
Cardiopulmonary events during hemodialysis: Effects of dialysis membranes and dialysate buffers
Authors: Munger, MA Ateshkadi, A Cheung, AK Flaharty, KK Stoddard, GJ Marshall, EH
Citation: Ma. Munger et al., Cardiopulmonary events during hemodialysis: Effects of dialysis membranes and dialysate buffers, AM J KIDNEY, 36(1), 2000, pp. 130-139
Pharmacy practice acts: A decade of progress
Authors: Young, MD Stilling, WJ Munger, MA
Citation: Md. Young et al., Pharmacy practice acts: A decade of progress, ANN PHARMAC, 33(9), 1999, pp. 920-926
Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure
Authors: Havranek, EP Thomas, I Smith, WB Ponce, GA Bilsker, M Munger, MA Wolf, RA
Citation: Ep. Havranek et al., Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure, J AM COL C, 33(5), 1999, pp. 1174-1181
Candesartan cilexetil: Comparison of once-daily versus twice-daily administration for systemic hypertension
Authors: Zuschke, CA Keys, I Munger, MA Carr, AA Marinides, GN Flanagan, TL Cushing, DJ Hayes, JL Michelson, EL
Citation: Ca. Zuschke et al., Candesartan cilexetil: Comparison of once-daily versus twice-daily administration for systemic hypertension, CLIN THER, 21(3), 1999, pp. 464-474
Risultati: 1-12 |